107 related articles for article (PubMed ID: 23863155)
1. Many roads from mTOR to eIF4F.
Thoreen CC
Biochem Soc Trans; 2013 Aug; 41(4):913-6. PubMed ID: 23863155
[TBL] [Abstract][Full Text] [Related]
2. Differential contribution of the MTOR and MNK pathways to the regulation of mRNA translation in meiotic and postmeiotic mouse male germ cells.
Messina V; Di Sauro A; Pedrotti S; Adesso L; Latina A; Geremia R; Rossi P; Sette C
Biol Reprod; 2010 Oct; 83(4):607-15. PubMed ID: 20574055
[TBL] [Abstract][Full Text] [Related]
3. mTOR signaling: implications for cancer and anticancer therapy.
Petroulakis E; Mamane Y; Le Bacquer O; Shahbazian D; Sonenberg N
Br J Cancer; 2006 Jan; 94(2):195-9. PubMed ID: 16404421
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of the host translation initiation complex eIF4F by DNA viruses.
Walsh D
Biochem Soc Trans; 2010 Dec; 38(6):1511-6. PubMed ID: 21118117
[TBL] [Abstract][Full Text] [Related]
5. Selective regulation of YB-1 mRNA translation by the mTOR signaling pathway is not mediated by 4E-binding protein.
Lyabin DN; Ovchinnikov LP
Sci Rep; 2016 Mar; 6():22502. PubMed ID: 26931209
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor 4F: a vulnerability of tumor cells.
Lee T; Pelletier J
Future Med Chem; 2012 Jan; 4(1):19-31. PubMed ID: 22168162
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 and CK2 coordinate ternary and eIF4F complex assembly.
Gandin V; Masvidal L; Cargnello M; Gyenis L; McLaughlan S; Cai Y; Tenkerian C; Morita M; Balanathan P; Jean-Jean O; Stambolic V; Trost M; Furic L; Larose L; Koromilas AE; Asano K; Litchfield D; Larsson O; Topisirovic I
Nat Commun; 2016 Apr; 7():11127. PubMed ID: 27040916
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin/eukaryotic initiation factor 4F pathway regulates follicle growth and development of theca cells in mice.
Zhang C; Liu XR; Cao YC; Tian JL; Zhen D; Luo XF; Wang XM; Tian JH; Gao JM
Reprod Fertil Dev; 2017 Apr; 29(4):768-777. PubMed ID: 26748416
[TBL] [Abstract][Full Text] [Related]
9. Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition.
Vo TT; Herzog LO; Buono R; Lee JS; Mallya S; Duong MR; Thao J; Gotesman M; Fruman DA
Sci Rep; 2021 Nov; 11(1):21689. PubMed ID: 34737376
[TBL] [Abstract][Full Text] [Related]
10. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
Pelletier J; Graff J; Ruggero D; Sonenberg N
Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
[TBL] [Abstract][Full Text] [Related]
11. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
12. SF2/ASF TORCs up translation.
Bushell M; Stoneley M; Spriggs KA; Willis AE
Mol Cell; 2008 May; 30(3):262-3. PubMed ID: 18471971
[TBL] [Abstract][Full Text] [Related]
13. Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F.
Sans MD; DiMagno MJ; D'Alecy LG; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G517-28. PubMed ID: 12773302
[TBL] [Abstract][Full Text] [Related]
14. Temporal and spatial regulation of translation in the mammalian oocyte via the mTOR-eIF4F pathway.
Susor A; Jansova D; Cerna R; Danylevska A; Anger M; Toralova T; Malik R; Supolikova J; Cook MS; Oh JS; Kubelka M
Nat Commun; 2015 Jan; 6():6078. PubMed ID: 25629602
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
16. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell].
Zubova SG; Shitikova ZhV; Pospelova TV
Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
18. Deconstructing mTOR complexes in regulation of Glioblastoma Multiforme and its stem cells.
Jhanwar-Uniyal M; Jeevan D; Neil J; Shannon C; Albert L; Murali R
Adv Biol Regul; 2013 May; 53(2):202-10. PubMed ID: 23231881
[TBL] [Abstract][Full Text] [Related]
19. [Mammalian target of rapamycin inhibitors for the targeted therapy of non-small cell lung cancer].
Lin Y; Zhang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):239-42. PubMed ID: 20450558
[TBL] [Abstract][Full Text] [Related]
20. mTOR Signalling in Health and Disease.
Proud CG
Biochem Soc Trans; 2011 Apr; 39(2):431-6. PubMed ID: 21428914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
